State Health Investment Project: Impact Evaluation Endline Survey, 2017
Nigeria, 2017
Get Microdata
Reference ID
NGA_2017_HRBFIE-EL_v01_M
Producer(s)
Eeshani Kandpal (World Bank)
Created on
Dec 05, 2022
Last modified
Aug 28, 2024
Page views
48792
Downloads
206
- Data files
- cardio_drugs_noid.dta
- Catchment_Area_noid.dta
- decr_services_noid.dta
- diagnostic_kits_noid.dta
- FP_drugs_noid.dta
- general_drugs_noid.dta
-
Health Facility
(HF1)_noid.dta - HF1_Sect08_noid.dta
- HF1_sect10A_noid.dta
- HF1_Sect10B_noid.dta
- incr_services_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
- malaria_drugs_noid.dta
- obstetric_care_noid.dta
- Q1611_positions_noid.dta
- services_noid.dta
- TB_drugs_noid.dta
- vaccines_noid.dta
- anc_patients_noid.dta
- HF3_HCP_Info_noid.dta
- HF4_HCP_Info_noid.dta
- HF4_patients_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
Patient DIRECT
OBSERVATION
(HF3_HF4)_noid.dta - HF5_ASSETS_noid.dta
- HF5_LIVESTOCK_noid.dta
- HF5_patients_noid.dta
- HF6_ASSETS_noid.dta
- HF6_LIVESTOCK_noid.dta
- HF6_patients_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
Patient EXIT
INTERVIEW
(HF5_HF6)_noid.dta -
Health Care
Provider
Interviews
(HF7)_noid.dta - HF7_Q202_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
- staff_roster_noid.dta
- Durable_Goods_noid.dta
- hhroster_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
NSHIP IE
Midline
Household Women
Questionnaire_noid.dta - Q16_13_noid.dta
- S5C_Assets_noid.dta
- S9_Vaccines_noid.dta
- Sec_05B_noid.dta
- Sec_06A_noid.dta
- Sec_06B_noid.dta
- Sec_06C_noid.dta
- Sec_07_noid.dta
Q12.02c: At what age should a child receive Pentavalent 2 vaccines? (HF7_Q1202C1)
Data file: staff_roster_noid.dta
Overview
Valid:
3222
Invalid:
-
Minimum:
-999999999
Maximum:
999
Type:
Discrete
Decimal:
0
Start:
4564
End:
4573
Width:
10
Range:
-999999999 - 999
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| -999999999 | 610 |
18.9%
|
|
| 0 | 5 |
0.2%
|
|
| 1 | 13 |
0.4%
|
|
| 2 | 12 |
0.4%
|
|
| 3 | 13 |
0.4%
|
|
| 4 | 34 |
1.1%
|
|
| 5 | 2 |
0.1%
|
|
| 6 | 115 |
3.6%
|
|
| 8 | 35 |
1.1%
|
|
| 9 | 9 |
0.3%
|
|
| 10 | 2168 |
67.3%
|
|
| 12 | 21 |
0.7%
|
|
| 14 | 80 |
2.5%
|
|
| 16 | 8 |
0.2%
|
|
| 18 | 3 |
0.1%
|
|
| 20 | 1 |
0%
|
|
| 24 | 1 |
0%
|
|
| 36 | 1 |
0%
|
|
| 999 | 91 |
2.8%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.